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  28 
Highlights 29 
• Duchenne’s muscular dystrophy is often associated with mental retardation 30 
• The association between dystrophin and excitatory neuronal function in 31 
hippocampal physiology is yet largely unexplored 32 
• We show that hippocampal function is largely preserved in the dystrophin-33 
lacking DBA/2J-mdx mouse model 34 
• Medium after-hyperpolarization is increased in the DBA/2J-mdx mouse model 35 
 36 
Abstract 37 
Dystrophin deficiency is associated with alterations in cell physiology. The functional 38 
consequences of dystrophin deficiency are particularly severe for muscle physiology, as 39 
observed in Duchenne muscle dystrophy (DMD). DMD is caused by the absence of a 427 kDa 40 
isoform of dystrophin. However, in addition to muscular dystrophy symptoms, DMD is 41 
frequently associated with memory and attention deficits and epilepsy. While this may be 42 
associated with a role for dystrophin in neuronal physiology, it is not clear what neuronal 43 
alterations are linked with DMD. Our work shows that CA1 pyramidal neurons from DBA/2J-44 
mdx mice have increased afterhyperpolarization compared to WT controls. All the other 45 
electrotonic and electrogenic membrane properties were unaffected by this genotype. Finally, 46 
basal synaptic transmission, short-term and long-term synaptic plasticity at Schaffer collateral 47 
to CA1 glutamatergic synapses were unchanged between mdx and WT controls. These data 48 
show that the excitatory component of hippocampal activity is largely preserved in DBA/2J-49 
mdx mice. Further studies, extending the investigation to the inhibitory GABAergic function, 50 
may provide a more complete picture of the functional, network alterations underlying impaired 51 
cognition in DMD. In addition, the investigation of changes in neuronal single conductance 52 
biophysical properties associated with this genotype, is required to identify the functional 53 
alterations associated with dystrophin deficiency and clarify its role in neuronal function.  54 
  55 
Introduction 56 
The 427 kDa isoform of dystrophin (Dp427) 1, is present in healthy striated/smooth muscle 57 
and neurons, particularly in the hippocampus, prefrontal cortex and cerebellum 2,3. The lack of 58 
dystrophin causes Duchenne muscular dystrophy (DMD) which involves progressive wasting 59 
of skeletal muscle and the replacement of muscle tissue with connective and adipose tissue, 60 
as well as the development of dilated cardiomyopathy in later stages of the disease 4,5. In 61 
addition, DMD has been associated with altered brain function, including attention deficits, 62 
memory impairments and increased risk of seizures, which suggests a role for dystrophin in 63 
brain function6. In the brain, neurons expressing the Dp427 isoform include cerebellar Purkinje 64 
cells, hippocampal and cortical pyramidal cells and cells in the amygdala7-10; other brain 65 
isoforms are Dp140 and the Dp71 11,12.  66 
The Dp427 isoform is highly localized in synaptic spines and post-synaptic densities (PSD), 67 
where it associates with a dystrophin-associated protein complex (DAPC) which spans the 68 
cell membrane and links the actin cytoskeleton with the extracellular matrix 13. Both spines 69 
and PSDs have a critical role for neurotransmission and synaptic plasticity, which underlie 70 
cognitive functions, including memory and learning14. The cognitive impairment associated 71 
with DMD has been linked to the effects of the lack of dystrophin in brain structures associated 72 
with memory, language and attention, including the hippocampus and the prefrontal cortex7,15. 73 
In addition, it should be noted that only one third of DMD patients show cognitive impairment16. 74 
The cognitive impairment can appear, in the absence of dystrophin, even without the muscular 75 
dystrophy symptoms, suggesting that the cognitive symptoms are a direct consequence of the 76 
lack of protein, rather than an epiphenomenon paralleling and caused by the motor 77 
impairment17. Finally, the lack of dystrophin has been associated with epilepsy, as the 78 
prevalence of epilepsy in DMD patients is significantly higher in comparison to control 79 
populations18-21.  80 
However, it is not clear yet how the lack of the Dp427 isoform of dystrophin may affect the 81 
biophysical properties of membrane conductance and synaptic machinery, responsible for 82 
neuronal excitability and synaptic transmission and plasticity, respectively. For example, the 83 
mdx mouse, the most commonly used mouse model for dystrophin deficiency and DMD, which 84 
lacks the expression of the Dp427 kDa dystrophin isoform, has been reported to show 85 
impaired spatial memory and enhanced long-term potentiation (LTP) of synaptic transmission 86 
in the hippocampus9,22, while other research groups have not observed differences in either 87 
spatial learning or hippocampal LTP23. Intriguingly, motivational differences between the mdx 88 
mouse and its wild type control can give conflicting operant conditioning, dependent on the 89 
type of behavioural characteristics being assessed24. The reasons for all these discrepancies 90 
are unclear; however, the absence of a mechanistic pathway leading from the absence of 91 
dystrophin to cognitive dysfunction contributes to the lack of consensus on the causal 92 
connection between DMD and neuronal function 25. In addition, such a variety of hippocampal 93 
function phenotypes may be associated with the unpredictability of mental retardation onset 94 
in people with DMD (only 1/3 of DMD patients show cognitive deficit)16.  95 
GABA-receptor density and clustering on post-synaptic membranes, and GABA dependent 96 
inhibitory neurotransmission have been shown to be altered in mdx mice. The frequency of 97 
GABAergic-dependent spontaneous inhibitory post-synaptic currents (IPSCs) is indeed 98 
increased in the amygdala pyramidal neurons of mdx mice, revealing a possible effect of this 99 
genotype in promoting the hyperexcitability of inhibitory interneurons in this brain area 9.  100 
Much less is known about the effect of the loss of dystrophin on basic electrotonic and 101 
electrogenic properties of neuronal membranes. In the light of all the above, in this study we 102 
investigated the effects of the absence of Dp427 on the excitability of hippocampal CA1 103 
pyramidal neurons as well as the functionality of Schaffer Collaterals – CA1 synapses in 104 
DBA/2J-mdx mice. This mouse line has been generated by backcrossing the more commonly 105 
used Bl/10-mdx mouse line onto a DBA/2J genetic background which results in a more severe 106 
pathology of the muscle (ref 37, Coley et al). Although our study was not designed to determine 107 
the effect of genetic background on neuronal parameters, we reasoned that the increased 108 
muscle weakness in the DBA/2J-mdx mice compared to the Bl/10-mdx mice might compound 109 
any effects of the lack of dystrophin per se because of additional mobility restrictions in the 110 
mice due to muscle weakness. To the best of our knowledge, no studies have investigated 111 
neuronal function in this DMD model.  112 
  113 
Materials and methods 114 
Experimental animals 115 
Male DBA/2J-mdx mice (The Jackson Laboratory, Bar Harbour, ME USA) and DBA2 wild-type 116 
mice (Envigo, UK) were group housed in animal facilities at the University of Reading on a 117 
12:12 hour light/dark cycle with standard chow and water available at libitum. In all 118 
experiments, DBA/2J-mdx mice were compared against age- and sex-matched wild-type 119 
mice. All experiments were carried out at the University of Reading under a United Kingdom 120 
Home Office licence in compliance with the Animals (Scientific Procedures) Act 1986.   121 
Preparation of brain slices.  122 
Animals were sacrificed using cervical dislocation in accordance with schedule 1 of the 123 
Animals (Scientific Procedures) Act (1986). The brain was rapidly removed and transferred to 124 
an ice cold cutting solution consisting of (in mM): 189 Sucrose, 10 D-Glucose, 26 NaHCO3, 3 125 
KCl, 5 MgSO4(7 H2O), 0.1 CaCl2, 1.25 NaH2PO4. Three hundred µm coronal sections were 126 
cut using a Leica VT1200 microtome and immediately transferred to a holding chamber 127 
containing artificial cerebrospinal fluid (aCSF) continuously perfused with carbogen. The 128 
composition of the aCSF was as follows (in mM): 124 NaCl, 3 KCl, 24 NaHCO3, 2 CaCl2, 1.25 129 
NaH2PO4, 1 MgSO4, 10 D-glucose. The slices were then allowed to recover for 30 min at 37° 130 
C and subsequently at room temperature for at least 1 hour prior to transfer into a recording 131 
chamber.  132 
Whole cell patch clamp recordings 133 
Slices were transferred to a recording chamber where they were submerged in carbogen-134 
equilibrated aCSF and maintained at a temperature between 33-34 °C. The recording 135 
chamber was secured on the stage of an Olympus BX51 upright microscope and individual 136 
CA1 pyramidal neurons were visualised using infrared differential interference contrast optics. 137 
Borosilicate glass microelectrodes with a resistance ranging from 3-7 MΩ were pulled, fire-138 
polished and filled with a K-Gluconate based internal solution consisting of (in mM): 120 mM 139 
K-gluconate, 10 mM Na2-phosphocreatine, 0.3 mM Na2-GTP, 10 mM HEPES, 4 mM KCl, 4 140 
mM Mg-ATP (pH 7.2, 280-290 mOsm). Following entry into whole cell configuration, a junction 141 
potential error of 15 mV arose due to the pairing of the pipette solution with the aCSF, which 142 
was corrected for arithmetically during analysis. Signals were recorded using a Multiclamp 143 
700A amplifier, digitised using a Digidata 1550B and stored for future analysis using pClamp 144 
10 software. 145 
 146 
All recordings were made from a defined pre-stimulus membrane potential set by injecting a 147 
continuous flow of bias current through the recording electrode. This facilitated the analysis of 148 
passive neuronal properties and action potential generation from pre-stimulus membrane 149 
potentials (Vm) of both -80 and -74 mV. In order to measure neuronal passive membrane 150 
properties a 500 ms, -100 pA hyperpolarising current was injected across the membrane from 151 
each Vm. The subsequent voltage deflection at the steady state of the hyperpolarisation was 152 
used to calculate the input resistance (Rin) of the membrane using Ohm’s law (V = IR). The 153 
extrapolation of a single exponential curve at an infinite time, fitted to the membrane charging 154 
response between 10 and 95% of the peak amplitude, was used to calculate the membrane 155 
time constant (τ). An approximation of capacitance was measured as the ratio between the τ 156 
and Rin.  157 
Sag, measured as the difference between the negative peak and the steady state 158 
hyperpolarisation, was expressed as a percentage of the peak hyperpolarisation in response 159 
to a 500 ms, -100 pA hyperpolarising current injection.   160 
Standard “Zap” protocols were used to measure subthreshold membrane resonance 161 
properties. Briefly, the ratio of the Fast-Fourier transform of the voltage response versus the 162 
current injection was calculated as a measure of the impedance profile of the pyramidal 163 
neurons (Z = Vfft/Ifft). Subsequently, the impedance versus frequency profile was smoothed 164 
with a 35-point moving average function. The maximal impedance (Z max) frequency at which 165 
this maximal impedance occurred (Peak frequency), and the quality factor of the resonator (Q) 166 
were quantified to facilitate comparisons between the genotypes. The quality factor of the 167 
resonator “Q” was calculated as the ratio between the impedance at peak frequency and the 168 
impedance at 0.5 Hz 26. 169 
In order to quantify neuronal excitability, a series of incremental 500 ms depolarising square 170 
current injections, ranging from 50 to 350 pA, were injected across the membrane. The 171 
number of action potentials (AP) generated for each current injection was used as a measure 172 
of excitability. The first AP fired in response to a 350 pA depolarising current step was used to 173 
compare action potential waveforms between the genotypes. AP threshold was quantified, 174 
defined as the voltage at which the rate of rise (dV/dt) surpassed 20 V s-1; the maximal rate of 175 
rise (RoR) was also measured for each cell as the highest value of the first derivative of voltage 176 
in time, within the AP duration; the AP width was measured at Vm = -15 mV; finally, the AP 177 
peak was measured as the Vm at which, following the ascending phase of the AP, dV/dt=0 178 
V*s-1. 179 
For the voltage-clamp experiments, outside-out, somatic, nucleated macropatches were 180 
excised as previously described 27. Pipette capacitance was neutralized and the series 181 
resistance was compensated for (10% – 80% correction). VC recordings were made for the 182 
quantitative evaluation of outward-going plateau voltage-gated K+ currents, by applying 30 ms 183 
voltage steps, growing in 10 mV increments and starting from a holding voltage of -90mV. 184 
Each recorded current amplitude was normalized to the membrane capacitance of the 185 
macropatch in order to account for differences in current amplitude arising from different sizes 186 
of the macropatch. The specific current (pA/pF) was plotted against the value of the voltage 187 
step.  188 
Field excitatory postsynaptic potentials 189 
Following the initial post-slicing recovery period, the slices were then transferred to a recording 190 
chamber in which they were submerged and continually perfused with aCSF, pre-equilibrated 191 
with carbogen and maintained at room temperature. Field excitatory postsynaptic potentials 192 
(fEPSPs) were elicited by delivering a short pulse of electrical current (0.1 ms) through 193 
tungsten bipolar stimulating electrodes. These stimulating electrodes were placed such as to 194 
stimulate axons of the Schaffer Collateral (SC) pathway. Borosilicate glass recording 195 
microelectrodes with a resistance ranging from 3-5 MΩ were pulled and filled with aCSF. 196 
Recorded signals were collected with a Multiclamp 700A amplifier, digitised with a Digidata 197 
1550B and stored for future analysis using pClamp 10 software.  198 
Input-output curves were constructed by incrementally increasing the current passing through 199 
the stimulating electrode and recording the evoked response (0 - 300 µA in 50 µA). For the 200 
rest of the experiment, the stimulus intensity was then set to induce 50% c.a. of the maximal 201 
response.  202 
Short-term plasticity was tested with a paired-pulse profile, consisting in 2 subsequent 203 
stimulating pulses, with inter-pulse intervals of increasing value (in ms): 10, 17, 32, 56, 100, 204 
170, 320, 560, and 1000.  205 
After a period of at least 20 minutes recording baseline responses at low frequency (0.033 206 
Hz), induction of LTP was attempted in the SC-CA1 pathway using a theta-patterned (5 Hz) 207 
burst stimulation (TBS) protocol. This consisted of 5 bursts of 10 stimuli at 100 Hz applied with 208 
an inter-burst interval of 200 ms. This was repeated 4 times with an inter-repeat interval of 20 209 
s. The fEPSPs were then followed for 1 hour before the TBS protocol was delivered to the 210 
other pathway and the fEPSPs were followed up for another hour. We have decided to use 211 
TBS over other existing LTP-induction protocols, such as high frequency stimulation 14, as 212 
TBS mimics the firing patterns observed in vivo in rodents performing a task leading to long-213 
term memory encoding 28-30. In addition, TBS results in the most effective NMDA- and voltage-214 
gated Calcium channel-dependent  form of long-lasting LTP 31-34. 215 
Data analysis 216 
Data were analysed using Clampfit 11. Statistical assessments of differences between 217 
genotypes were made using unpaired two-tailed students t-tests and two-way analysis of 218 
variance (ANOVA) as appropriate. Figures were prepared with Origin Pro 2018. All results 219 
were expressed as mean ± standard error of the mean (SEM). The experimental “n”, refers to 220 
the number of slices and to the number of cells we have recorded from in the field potential 221 
and patch-clamp experiments, respectively. 222 
 223 
Results 224 
Most of the studies investigating the functional correlation between the lack of dystrophin and 225 
neuronal and brain dysfunction have focused on the alteration of GABAergic 226 
neurotransmission. Our study aimed to characterize, in DBA/2J-mdx mice, the effects of the 227 
lack of dystrophin on the electrogenic and electrotonic membrane properties of CA1 pyramidal 228 
neurons (CA1-PCs). In addition, we investigated whether basal synaptic transmission, short-229 
term synaptic plasticity and long-term potentiation were affected in DBA/2J-mdx mice. Field 230 
potential, extracellular recordings were carried out in 9 m/o mice, while single cell, whole-cell 231 
patch-clamp recordings were carried out in 7 m/o mice. At the chosen age the mice show 232 
significant muscle atrophy and weakness (data not shown). In addition, we have observed that 233 
DBA/2J-mdx mice show less rearing activity but no changes in other activity related 234 
parameters, when tested in activity cages (unpublished observations). Whether this is due to 235 
the significant reduction in muscle strength in these mice, or due to reduced motivation to act 236 
or explore is not known. Previous studies have shown that the mdx genotype is associated 237 
with cognitive impairment35. However, to our knowledge, there are no available data on the 238 
memory performance in DBA/2J-mdx mice.  239 
First, we tested the effect of the DBA/2J-mdx genotype on synaptic transmission (Figure 1A; 240 
two-way ANOVA; source of variability: genotype; F=3.622, P=0.06), short-term plasticity 241 
(Figure 1B; two-way ANOVA; source of variability: genotype; F=0.037, P=0.847) and LTP 242 
(Figure 1C; unpaired two-tailed t-test; P=0.97). None of these parameters were affected by 243 
the DBA/2J-mdx genotype.  244 
Synaptic transmission and plasticity are often regarded as the neuronal correlates of cognitive 245 
functions, such as memory and learning; hence a change/impairment in these functional 246 
outcomes would be expected to underlie cognitive dysfunction. However, changes in single 247 
cell membrane excitability properties are also fundamental functional correlates underlying 248 
cognition, even in the absence of synaptic input/output (I/O), (paired-pulse profile) PPP and 249 
long-term potentiation (LTP) alterations. For this reason, we measured the electrotonic and 250 
electrogenic membrane properties in CA1-PCs from DBA/2J-mdx and age-matched WT 251 
controls.  252 
 253 

























































First, no differences were observed in the resting membrane potential (RMP) between 254 
genotypes. To avoid biases arising from cell-to-cell variability in RMP, all the other properties 255 
were measured from a pre-stimulus potential of -80 mV, obtained with a constant current 256 
Figure 1. DMD-associated DBA/2J-mdx genotype is not associated with impairments 
of synaptic transmission and plasticity. A. Basal synaptic transmission was measured 
as the relationship between fEPSP amplitude and stimulus intensities. Input/output curves 
were built by plotting the amplitude of SC-CA1 fEPSPs amplitude vs stimulus intensity. Two-
way ANOVA does not reveal significant differences between genotypes (F=3.622 p=0.06) 
nor interactions between genotype and stimulus intensity (F=0.104 p=0.991). B. Paired 
pulse ratios of SC-CA1 fEPSPs, tested at increasing inter-pulse intervals, were not different 
between genotypes (two-way ANOVA; F=0.037, p=0.847) and no interaction was observed 
between genotype and ISI (two-way ANOVA; F=0.499, p=0.855). C. LTP induction in SC-
CA1 synapses was not affected by genotype (Unpaired T-Test on the last 10 minutes of 


























































































































Figure 2. DMD-associated DBA/2J-mdx genotype does not affect the electrotonic, 
subthreshold membrane properties in hippocampal CA1-PCs. A. Vm average ± SEM 
hyperpolarization, upon the injection of a -50 pA, 500 ms current step injection, for each genotype. 
This approach was used to measure properties like Rin (C), Tau (E) and capacitance (G), which were 
not affected by the mdx genotype (unpaired t-test, two tailed). B. Average ± SEM smoothed 
impedance (sZ), measured upon the injection of a current oscillating at subthreshold values, with 
frequencies comprised between 0.5 – 20 Hz, is plotted here. Resonance properties were measured 
between genotypes and no effect was observed between mdx mice and WT controls on peak Z (D), 
peak frequency (F) and quality factor of the resonator Q (H). The reported “n” refers to the number 
of cells. 
injection. No differences were observed in electrotonic passive properties (Figure 1), neither 258 
under the injection of a continuous current (Figure 2A, C, E and G) nor the injection of a 259 
subthreshold oscillating current, with a frequency linearly increasing between 0.5 Hz and 20 260 
Hz within a 30 s time window (Figure 2B, D, F, and G). This latter approach was used to 261 
investigate the effects of DBA/2J-mdx genotype on the resonance properties of CA1-PCs, 262 
represented as Peak Z, Peak Frequency and quality factor of the resonator – Q, as previously 263 
described 36. Mean, SEM and P values for subthreshold properties in DBA/2J-mdx and control 264 
mice are reported in Table 1. 265 
 266 
Table 1. Subthreshold passive and resonance membrane properties of CA1 267 
pyramidal neurons in hippocampal slices from DBA/2J-mdx mice and age-268 
matched WT controls. 269 
 WT n=29 cells mdx n=25 cells 
Property Average SEM Average SEM P 
RMP (mV) -71.4 (n=39) 2.6 -73.5 (n=33) 3.0 0.6 
Rin (MΩ) 126.0 8.0 146.0 11.2 0.1 
tau (ms) 15.3 0.8 17.0 1.3 0.3 
Capacitance (pF) 110.0 5.3 105.4 8.3 0.6 
Peak frequency (Hz) 3.1 0.3 3.2 0.2 0.7 
Q 1.11 0.01 1.10 0.02 0.9 
Peak Z (MΩ) 196.5 31.1 180.4 18.8 0.7 
 270 
 271 
We tested the firing rate properties of CA1-PCs in DBA/2J-mdx and WT controls upon the 272 
injection of square current injections of progressively increasing intensity. The average firing 273 
rate was not affected by genotype (Figure 3B; two-way ANOVA, source of Variability: 274 
genotype, F=0.291, P=0.590). 275 
In addition, the AP waverform properties (Figure 4), namely width (Figure 4C), maximal rate 276 
of rise (dVm/dT) of the AP (RoR) (Figure 4D), peak (Figure 4E) and threshold were not affected 277 
by genotype. For averages ± SEM and P values see Table 2. 278 
279 
Post-firing properties, such as the medium component of after-hyperpolarisation (mAHP), 280 
were tested to investigate the effect of DBA/2J-mdx genotype on the relative refractory 281 
period, as an indirect measure of neuronal excitability. mAHPs were evoked by the 282 
subsequent application of 5-10-15-20-25, 2 nA-2ms depolarising current steps. The 283 
amplitude of the mAHP, comprised of the repolarization of the last evoked AP and the 284 
subsequent 500 ms, was measured across number-of-pulses conditions and between 285 
genotypes. Figure 5A shows 286 








































Figure 3. DMD-associated DBA/2J-mdx genotype does not affect the AP firing rates 
upon depolarization of the Vm, in hippocampal CA1-PCs. A. Example traces of CA1-
PCs firing APs upon the injection of 100 – 200 – 300 pA, 500 ms, depolarizing current 
steps. B. The number of APs fired at each current intensity (50 – 350 pA, with 50 pA 
increases), within a 500 ms time window, was plotted as a measure of average firing 
excitability. No effect of the genotype (two-way ANOVA; F=0.291, p=0.590) nor interaction 
between genotype and current intensity (two-way ANOVA; F=0.745, p=0.590) was 
observed on CA1-PCs average firing properties. The reported “n” refers to the number of 
cells. 
287 
the average ± SEM boundaries of the medium and slow components of the AHP evoked by 288 


































































































Figure 4. DMD-associated DBA/2J-mdx genotype does not affect the AP waveform 
properties in hippocampal CA1-PCs. A. Average ± SEM traces of the first action 
potential evoked by a 350 pA, 500 ms current step, grouped between genotypes. B. 
Average ± SEM phase-plots, grouped between genotypes. CA1-PCs action potential 
waveform properties, such as width (C), maximal rate of rise (D), peak value (E) and 
threshold (F) are not different between mdx and WT controls. The reported “n” refers to 
the number of cells. 
DBA/2J- mdx CA1-PCs. Two-way ANOVA showed a significant effect of genotype in 290 
increasing the mAHP in DBA/2J-mdx mice, compared to WT controls (Figure 5C; two-way 291 

























































Figure 5. DBA/2J-mdx genotype is associated with the increase of the amplitude of 
post-burst medium but not slow afterhyperpolarizations in hippocampal CA1-PCs. A. 
Average ± SEM traces of the mAHP evoked by 20 pulses, 2 nA – 2 ms, delivered at 50 Hz, 
grouped by genotype. An increased mAHP is observed in CA1-PCs from mdx mice, but no 
genotype effect was apparent on slow AHP (B). C. The overall mAHP, evoked by 5-10-15-
20-25 2 nA / 2 ms pulses, delivered at 50 Hz, was bigger in mdx in comparison to WT 
controls (two-way ANOVA, F=9.687, p=0.002); however, no interaction was observed 
between genotype and number of pulses. The reported “n” refers to the number of cells. 
Table 2. Action potential properties of CA1 pyramidal neurons in hippocampal 295 
slices from DBA/2J-mdx mice and age-matched WT controls. 296 
 WT n=29 cells mdx n=25 cells 
Property Average SEM Average SEM P 
AP_peak (mV) 18.1 2.7 18.2 2.6 1 
AP_width (ms) 0.99 0.05 1.01 0.05 0.7 
AP_thres (mV) -56.0 1.4 -57.5 2.1 0.5 
AP_max_dvdt (Vs-1) 279.5 23.5 278.1 23.6 1 
 297 
The generation of mAHP has been ascribed to the gating properties of non-inactivating, 298 
voltage-gated K+ currents, such as IK 36. For this reason, we decided to measure the 299 
biophysical properties of voltage-gated non-inactivating IK. Voltage-clamp recordings on 300 
nucleated, somatic, outside-out macropatches were performed and cell-to-cell Boltzmann fits 301 
were performed to calculate the maximal current density (Imax) and the half-activation potential 302 
(V1/2). However, no significant differences were observed between genotypes for both the Imax 303 
(Figure 6; DBA/2J-mdx Imax = 99.7 pA/pF ± 54.4 pA/pF vs WT Imax = 136.9 pA/pF ± 62.3 pA/pF; 304 
P=0.7) and V1/2 (DBA/2J-mdx V1/2 = -42.6 mV ± 1.9 mV vs WT V1/2 = -43.3 mV ± 1.02; P=0.7). 305 
Discussion 306 
We investigated the effects of the lack of dystrophin on both CA1-PCs intrinsic membrane 307 
excitability and SC-CA1 glutamatergic synaptic function in a mouse model of muscular 308 
dystrophy, the DBA/2J-mdx37,38. The DBA/2J-mdx mouse model, while carrying the same 309 
mutation, shows a more severe phenotype, in comparison to mdx mice on  a Bl/10 genetic 310 
background 37,38. In fact, the DBA/2J background contains genetic modifier loci, which are 311 
responsible for the increased severity of symptoms observed in the DBA/2J-mdx mice 39. To 312 
our best knowledge, this is the first-time brain function has been tested in this model. Our main 313 
observation was that while synaptic function, electrotonic and firing properties were unaffected 314 
by the genotype, the mAHP was bigger in DBA/2J-mdx mice than in controls. 315 
We have chosen to carry out the recordings on adult mice, aged 7 and 9-month-old. These 316 
ages have been chosen because, while DMD is a disorder mostly affecting people during 317 
development, we were interested to assess the long-term effects of dystrophin deficiency on 318 
hippocampal function. In fact, understanding and predicting brain dysfunction associated with 319 
DMD, may have a critical role on people’s quality of life, should a novel treatment for DMD be 320 
developed. While investigating basal synaptic transmission and short-term synaptic plasticity 321 
in dystrophin deficient models is novel, LTP has been tested by other groups, showing 322 
contrasting results: while some have observed enhanced LTP in dystrophin deficient mice 9,22, 323 
others have not found any effect 23. Our results fit with the latter. Part of the explanation for 324 
the discrepancy  325 
 326 















































































Figure 6. The DBA/2J-mdx genotype does not affect non-inactivating K+ currents in 
CA1-PCs. A. Example of an outside-out nucleated somatic macropatch, pulled from a 
CA1-PCs at the end of current-clamp recordings. B. Example trace of inward and outward 
currents evoked by a +30 mV voltage step: because of the fast inactivating kinetics of INa 
and IA, we focused our measures on the inactivating component of voltage-gated outward 
currents. C. IK current densities from mdx and WT controls plotted versus the intensity of 
the voltage step. Cell-to-cell fitting of a Boltzmann function was performed to measure 
somatic IK maximal current density and V1/2. Cell-to-cell analysis of the biophysical 
properties of CA1-PCs’ IK, revealed no effect of the mdx genotype on somatic IK V1/2 (C) 
and maximal current density (D). Scale bar: 5 μm. 
between the results obtained by different groups may be the different conditions used in each 327 
study. First, the LTP-inducing stimulation protocol used in each study is different. In fact, both 328 
repeated, strong (2x1s at 100Hz every 20 s) and single, weak (1x1s at 30Hz) high frequency 329 
stimulation resulted in a genotype-dependent LTP enhancement in mdx but not in mdx3cv mice 330 
9,22; however, in vivo LTP experiments on mdx mice, using 3x1s 100 Hz every 20 s HFS, did 331 
not show any genotype-related change in mdx mice 23; finally, our experiments were carried 332 
out in DBA/2J-mdx mice, using theta-patterned burst (100 Hz) stimulation. Although 333 
experiments were carried out in three different DMD mouse models (mdx, mdx3cv & DBA/2J-334 
mdx) which differ in the severity of the dystrophic pathology, it is currently not possible to 335 
conclude whether this influences synaptic plasticity in the brain, because of the use of different 336 
protocols by different groups to induce LTP and the fact that dystrophin isoform expression 337 
differs between mdx, mdx3cv and DBA/2J-mdx mice. Given that the muscular pathology of 338 
DMD patients is much more severe than that of the mdx mouse, and that muscle-secreted 339 
and physical activity-induced factors have an influence on brain neurogenesis and synaptic 340 
plasticity 40 it would be of interest to determine whether severity of muscle pathology affects 341 
synaptic plasticity in DMD mouse models. Our data, obtained from the DBA/2J-mdx mouse 342 
model, which displays significant muscle atrophy and fibrosis, show no deficit in hippocampal 343 
LTP (Figure 1). 344 
Previous work reported that the lack of dystrophin leads to decreased GABAergic 345 
neurotransmission 41,42, due to decreased GABA-A clustering on post-synaptic densities 7,43,44. 346 
Reduced GABAergic neurotransmission has been proposed to be the possible mechanism 347 
underlying the increased prevalence of epilepsy in boys with DMD 45,46 and enhanced 348 
hippocampal LTP in DMD mouse models 9,47. In addition, the Dp71 isoform-dependent 349 
dysregulation of the potassium Kir4.1 channel has been proposed as an 350 
alternative/complementary mechanism of action responsible for epilepsy in DMD patients. 351 
However, it is known that altered synaptic function and epileptiform hypersynchronous 352 
network activity also rely on the presence  of single cell membrane hyperexcitability 27,48-52. As 353 
we did not observe any change in basal synaptic transmission, short- and long-term synaptic 354 
plasticity in DBA/2J-mdx mice, we decided to further investigate the effects of lack of 355 
dystrophin on the intrinsic physiological properties of the CA1-PC’s plasma membrane, as a 356 
possible neuronal correlate of DMD-associated brain dysfunction. While electrotonic and firing 357 
properties were unchanged between genotypes, the after-hyperpolarization was significantly 358 
bigger in DBA/2J-mdx mice. mAHP is mediated by voltage-gated K+ channels (VGKC) 53. To 359 
assess the possible role of VGKC for the alteration of mAHP in mdx mice, we performed 360 
outside-out nucleated macropatch recordings to assess the biophysical properties of outward 361 
voltage-gated currents, as previously reported 27,54. We did not observe any significant effect 362 
of genotype on such current. However, a more detailed investigation of DBA/2J-mdx-363 
dependent alterations of biophysical properties is due, as in our native system we could not 364 
tease apart the role of each conductance responsible for voltage-gated K+ currents. In fact, 365 
dystrophin deficiency has been linked to an array of changes in membrane K+ conductances 366 
in cardiomyocytes, mediated by different signalling mechanisms. For example, inward rectifier 367 
K+ (Kir) current densities 2.1 were decreased in conditions of dystrophin deficiency 55 but no 368 
changes in the protein channel levels were observed, suggesting a change in trafficking rather 369 
than expression. In fact, Kir 2.1 is functionally and structurally connected to dystrophin via 370 
syntrophin 56 so it has been hypothesized that dystrophin deficiency may result in reduced 371 
presence of this conductance on the plasma membrane. However, Kv 2.1 and 1.5 currents, 372 
mediating the slow inactivating component of Ik, are also impaired in cardiomyocytes; they are 373 
connected to dystrophin via the F-actin and α-actinin-2 network. For this reason, we 374 
hypothesize that, in neurons, the lack of dystrophin may result in increased mAHP via 375 
syntrophin mediated altered docking of M-current-generating voltage-gated conductances, 376 
such as Kv 7. In fact, Kv7.x channels have been reported to mediate the mAHP 36.   377 
While previous work has been carried out on the intrinsic excitability of cerebellar Purkinje 378 
cells, showing reduced excitability due to hyperpolarized RMP in dystrophin-deficient mice 57, 379 
such measures have not been performed before in the hippocampus. 380 
These observations reinforce the idea that dystrophin may play a key role in brain physiology, 381 
regulating both motor and cognitive functions. Several lines of evidence show that dystrophin 382 
expression is altered in non DMD patients: for example, dystrophin expression is reduced in 383 
people with different forms of epilepsy, such as temporal mesial lobe epilepsy 58,59, sclerotic 384 
hippocampus 60 and in focal cortical dysplasia 61. However, while the same phenotype has 385 
been observed in the piriform cortex of pilocarpine-induced status epilepticus rats rodent 386 
models of epilepsy 62,63, no changes in dystrophin expression have been found in the 387 
hippocampus of these animals. On the other hand, dystrophin almost disappeared from the 388 
granule cells of the dentate gyrus, following the induction of seizures in mice treated with kainic 389 
acid 46. Such diversity of experimental outcomes somehow reflects the discrepancies 390 
observed in the effects of dystrophin deficiency on excitatory synaptic function and it probably 391 
reveals the generalized lack of knowledge about the role of this protein on brain physiology. 392 
Our results showed increased mAHP in CA1-PCs: this observation may have consequences 393 
on network function and cognitive decline observed in people with dystrophin deficiency. In 394 
fact, the mAHP corresponds to the refractory period following the AP and has a key role in 395 
determining the ability of a single neuron to sustainably fire 36. An increased mAHP amplitude 396 
may result in reduced excitability of the neural network. This, in turn, may account for the 397 
cognitive impairment paralleling dystrophin deficiency and be an adaptive mechanism due to 398 
increased network excitability. However, the consequences of the increased mAHP in 399 
dystrophin deficient mice, both at network and behavioural level, require a more detailed 400 
investigation.  401 
It should also be highlighted that while our investigation provides important insights into the 402 
alterations of hippocampal neuronal function associated with the lack of Dp427 isoforms, 403 
cognitive deficits are more significant in DMD patients which lack expression of shorter 404 
dystrophin isoforms derived from downstream promoters on the dystrophin gene, in addition 405 
to the full length Dp427 isoform 64. Whether this is because of a specific role for the shorter 406 
dystrophin isoforms or whether this is simply due to the further reduction of the presence of 407 
C-terminal dystrophin protein domains in the cell is unknown. However, it is currently not 408 
possible to study the role of the shorter dystrophin isoforms in isolation due to the mechanism 409 
by which these different isoforms are generated, but it is possible to isolate the role of the 410 
Dp427 isoform.  411 
For this reason, we should be cautious in translating these data to all DMD patients. 412 
Nonetheless, we believe the results presented here provide insight into the general role of 413 
Dp427 in hippocampal function and suggest that the severe muscle dysfunction observed in 414 
these mice does not affect most of the CA1 PCs membrane properties. 415 
In addition, the analysis of inhibitory interneurons’ intrinsic properties in dystrophin deficient 416 
mice is required to better clarify the single cell alterations, which may mechanistically explain 417 
the effects of dystrophin deficiency on brain function. Finally, clarifying the role of dystrophin 418 
in cognition and the pathological effects of its deficiency in brain function may provide evidence 419 
of common pathogenic mechanisms between different disorders resulting in cognitive deficit, 420 
including DMD, Alzheimer’s disease and epilepsy. This may eventually inform the 421 
development of a unified model for the onset different brain diseases resulting in impaired 422 
cognition.  423 
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